Jubilant Life Sciences |

Jubilant Life Sciences engaged in manufacture of APIs, solid dosage formulations, radio pharmaceuticals, allergy therapy and life science ingredients.

What section would you like to update?
  • Company Logo
  • Company Name & URL
  • Company Description
  • Founded Date
  • Company Status
  • HQ Address
  • Social Links
  • CEO Name & Picture
  • Competitor Set
  • Funding Events
  • Acquisition Events

If you'd like to make any changes to this portfolio we'd be happy to help. Please send info/sources to support@owler.com.


We'll be back up as soon as possible.

Visit owler.uservoice.com for FAQs

Jubilant Life Sciences Revenue, Funding, Number of Employees, Competitors and Acquisitions

JUBILANT LIFE SCIENCES CEO

Hari S. Bhartia

Managing Director

Hari S. Bhartia

Approval Rating: 69/100

WEIGH-IN

How would you rate Hari S. Bhartia as a CEO?

negative
You
neutral
You
positive
You

Founded:

1978

Headquarters:

NoidaUttar Pradesh

Status:

PublicBombay Stock Exchange530019

Industry Sector:

Life Sciences

Medical Research

Completeness:

100%

KEY STATS

Revenue

- -

What is Jubilant Life Sciences's revenue?

<1M

Employees

- -

How many people work at Jubilant Life Sciences?

Followers on Owler

- -

FOLLOW
UNFOLLOW

TOP COMPETITORS

Add a new competitor:

Thanks for your contribution!

Recalculating The Competitive Graph now...

ADD

Jubilant Life Sciences was founded in 1978 and its headquarters is located in Noida, Uttar Pradesh, IN. Jubilant Life Sciences has $925.4M in revenue and 2389 employees. Jubilant Life Sciences' top competitors are Dr.Reddy's, Lupin Pharmaceuticals and Sun Pharma.

Jubilant Life Sciences Competitive Set

COMPANYLEADERSHIPCEO SCORE

EMPLOYEES
(ESTIMATED IF PRIVATE)

TOTAL FUNDING

REVENUE
(ESTIMATED IF PRIVATE)

LIKELY OUTCOME
Jubilant Life SciencesJubilant Life Sciences ceo

Hari S. Bhartia

Managing Director

69/100
1Dr.Reddy's ceoDr.Reddy's

G V Prasad

CEO

76/10022,671
$2.2B
2Lupin Pharmaceuticals ceoLupin Pharmaceuticals

Vinita Gupta

CEO

68/100
$2B
3Sun Pharma ceoSun Pharma

Dilip S. Shanghvi

Managing Director

68/10030,000
$4.4B
4Wockhardt ceoWockhardt

Habil Khorakiwala

Founder & CEO

74/1007,900
5Zydus ceoZydus

Pankaj R. Patel

Managing Director

77/10012,227
$54.7B
6Glenmark ceoGlenmark

Glenn Saldanha

CEO

85/1007,000
$824.9M
7Aurobindo Pharma ceoAurobindo Pharma

Govindarajan Narayanan

Managing Director

74/10013,288
$1.6B
8Cadila Pharmaceuticals ceoCadila Pharmaceuticals

Dr. Rajiv I. Modi

Managing Director

50/100
$100M

Jubilant Life Sciences Revenue History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

$

Community Estimate

UPDATE THIS

Jubilant Life Sciences Employee History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

Community Estimate

UPDATE THIS

Jubilant Life Sciences Leadership

NAMETITLESOCIAL MEDIA
Hari S. Bhartia
Hari S. Bhartia

Managing Director

Managing Director- -

Jubilant Life Sciences Acquisitions

COMPANY ACQUIRED ACQUISITION DATEAMOUNTDESCRIPTION
undefinedMay 2017undisclosed

Jubilant Life Sciences' latest acquisition was in May 2017.

Jubilant Life Sciences News

Jubilant Life Sciences: JUBILANT PHARMA GETS USFDA NOD FOR SYMMETREL'S GENERIC VERSIONNew Delhi: Drug firm Jubilant Life Sciences today said its subsidiary has received final approval from the US health regulator for Amantadine Hydrochloride tablets, an anti-viral and anti-Parkinsons drug.btvi
Jubilant Life Sciences: Jubilant gets ANDA for Amantadine Hydrochloride TabletsThis is the ninth approval that we have received from the USFDA during the current financial year.India Infoline
Jubilant Life Sciences: Jubilant Life gains on ANDA approval for generic drugThe stock was up 3.4% at Rs 961 in intra-day trade, extending its past two days 3% gain on BSE.Business Standard
Jubilant Life Sciences: Jubilant receives ANDA approval for Clonidine Hydrochloride ER TabletsThere are several players in gKapvay already hence we do not see this as a major positive for the stock.India Infoline
Over the last seven days, Jubilant Life Sciences' press coverage more than tripled, up to 11 mentionsJubilant Life Sciences made the news 11 times in the past week, including articles in Moneycontrol, Business Standard and Livemint. This is about 11 times more than the usual press coverage the company receives. Its top competitor, Dr.Reddy's, was mentioned nine times and close competitor Glenmark was featured in three articles.
Jubilant Life Sciences: Jubilant Life Sciences Q3 net surges 80% to Rs 2.12 bn on robust salesThe company continues to reduce debt levels through internal cash generation for a strong balance sheetBusiness Standard
Jubilant Life Sciences: Jubilant Life Sciences Ltd announces changes in Board of DirectorsJubilant Life Sciences Ltd announces changes in Board of Directors...Equity Bulls
Jubilant Life Sciences: JUBILANT LIFE UP 17%, M-CAP RISES BY RS 1,762-CROREJubilant Life Sciences today settled with gains of nearly 17 per cent and added Rs 1,761.64 crore to its market capitalisation after the company reported strong December quarter earnings.BTVI
Jubilant Life Sciences: Jubilant Life receives green nod for Rs 2.5-bn greenfield pesticide projectThe company has total 20 hectares of area within the Bharuch SEZ, which is operated by Jubilant Infrastructure LtdBusiness Standard
Jubilant Life Sciences: Jubilant Life gains as Motilal Oswal raises target on attractive valuations, earnings growthMotilal Oswal has reiterated Buy rating on the stock with increased price target at Rs 957 (from Rs 861 per share), citing attractive valuations.Moneycontrol

SEE MORE

SEE LESS

Jubilant Life Sciences Website History

Screengrabs of how the Jubilant Life Sciences site has evloved. (Click to expand)

Jubilant Life Sciences website history

Sep 2017

Jubilant Life Sciences website history

May 2017

Jubilant Life Sciences website history

Feb 2017

Jubilant Life Sciences website history

Nov 2016

Jubilant Life Sciences website history

Aug 2016

Jubilant Life Sciences website history

May 2016

Jubilant Life Sciences website history

Feb 2016

Jubilant Life Sciences website history

Nov 2015

Jubilant Life Sciences website history

Jul 2015

Jubilant Life Sciences website history

Apr 2015

Jubilant Life Sciences website history

Nov 2014

Jubilant Life Sciences website history

Aug 2014

Jubilant Life Sciences website history

May 2014

Owler has collected 13 screenshots of Jubilant Life Sciences' website since May 2014. The latest Jubilant Life Sciences website design screenshot was captured in Sep 2017.

Jubilant Life Sciences Headquarters

undefined company logo

1A, Sector 16A

Noida, Uttar Pradesh 201301

91-120-436-1000

Driving Directions

google map

Jubilant Life Sciences Summary Information

Jubilant Life Sciences engaged in manufacture of APIs, solid dosage formulations, radio pharmaceuticals, allergy therapy and life science ingredients. Jubilant Life Sciences was founded in 1978. Jubilant Life Sciences' headquarters is located in Noida, Uttar Pradesh, IN 201301. Jubilant Life Sciences' latest acquisition was . Jubilant Life Sciences' Managing Director, Hari S. Bhartia, currently has an approval rating of 69%. 100% of Owler community believes the stock will go Up. Jubilant Life Sciences has 2389 employees and reported 925.4M in revenue [trailing four quarters].

Jubilant Life Sciences's Managing Director, Hari S. Bhartia, currently has an approval rating of 69%. Jubilant Life Sciences's primary competitors are  Dr.Reddy's Lupin Pharmaceuticals Sun Pharma.

Visit the Jubilant Life Sciences website to learn more.